Search
+
    SEARCHED FOR:

    DRUG FOR CORONAVIRUS

    His grandfather died of pancreatic cancer: This Hyderabad startup founder is using AI to develop a personalised cancer vaccines

    Hyderabad-based biotech startup PopVax, founded by Soham Sankaran, is developing AI-powered personalised cancer vaccines using mRNA technology. Inspired partly by his family's experience with pancreatic cancer, he aims to help the immune system identify and attack cancer cells using treatments designed around individual patients' tumour genetics.

    Nobel 2026: Ozempic, Mounjaro research tipped for medicine prize

    The 2026 Nobel season is set to reveal the winners of various prestigious awards, starting with medicine. The medicine prize is anticipated to acknowledge research on appetite-regulating hormones related to weight-loss drugs. Alongside this, other fields such as skin regeneration and immunology are also potential candidates for recognition. The peace prize is expected to generate significant interest due to last year's controversial winner.

    COVID-19 had a scientific head start; the next pandemic virus may be a stranger. NVIDIA and Google DeepMind are using AI to map 2,800 viruses before the next outbreak

    An international collaboration has developed a dataset of predicted protein structures from more than 2,800 viruses. This data is accessible through the AlphaFold Database, aiding in pandemic preparedness. Researchers can accelerate their investigations of new viruses using this information for potential treatments. The dataset provides insights into protein interactions, making it a valuable resource for global scientists.

    Tech Mahindra expects to begin trials for planned COVID drug in 3-4 months

    The company along with Reagene Biosciences has filed for the patent for a molecule that can be used to develop a drug against coronavirus. Makers Lab started the computational modelling analysis of the coronavirus. Based on computational docking and modelling studies, Makers Lab and its partner decided to develop a single molecule from a list of 8,000 USFDA-approved molecules.

    Scientists find new drug target to treat coronavirus, fight future pandemic

    The latest study, published in the journal Science Signaling, provides critical information that could aid drug development against future coronaviruses as well as SARS-CoV-2.

    Tech Mahindra, Reagene to file patent for molecule that potentially attacks coronavirus

    Tech Mahindra Global Head (Makers Lab) Nikhil Malhotra told that the company along with its partner is applying for patenting on which further testing will be done. Markers Lab is the research and development arm of Tech Mahindra.

    The Economic Times
    BACK TO TOP